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We have recently reported that excessive synthesis of
proinflammatory cytokines such as interleukin-6 (IL-
6) and IL-8 may play a role in the pathogenesis of
mesenteric  infarction.1 IL-4,  IL-10  and  IL-13  are
classified as anti-inflammatory cytokines because they
reduce the secretion of proinflammatory cytokines by
stimulated monocytes/macrophage.2–4 During several
inflammatory states anti-inflammatory cytokines are
elevated suggesting their putative regulatory role in
limiting the duration and extent of the acute inflam-
matory response.5,6We have investigated (using ELISA
kits from TEBU, France) the concentration of IL-4, IL-
10 and IL-13 in the plasma of three patients with a
mesenteric  infarction  before  multiple  organ  failure
development  and  in  10  atherosclerotic  patients.
Plasma  IL-10  levels  were  significantly  (P =  0.0001,
Mann–Whitney U-test) higher in patients with mesen-
teric  infarct  (93.5  ±  71.9pg/ml)  than  in  athero-
sclerotic patients (3.2 ± 0.6pg/ml). In contrast, IL-4
and  IL-13  were  not  detected  in  the  plasma  of
mesenteric infarct and atherosclerotic patients.
As for other cytokines detected in higher circulat-
ing  levels  during  mesenteric  infarct,1 IL-10  also
represents  a  marker  of  the  exacerbation  of  the
cytokine  production  in  these  patients. The  clinical
usefulness of these elevated IL-10 plasma concentra-
tions  requires  further  evaluation.  It  might  be  sug-
gested  that  they  could  reflect  an  attempt  by  the
organism to decrease the circulating proinflammatory
cytokine  activity.  Despite similar  activities  between
IL-4, IL-10 and IL-13 on the synthesis of inflammatory
cytokines  by  activated  mononuclear  cells,2–4 we
found that IL-4 and IL-13 are not elevated in plasma
during mesenteric infarct indicating that the produc-
tion of  the  various  anti-inflammatory  cytokines  are
differently regulated in these patients.
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